⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
HIF-1α in Metabolic Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-23 — Mitochondrial Transplantation Rejuvenates Aging Heart by Restoring Mitophagy Flux via the HIF‐3α‐BNIP3 Axis: cross-connection with pink1-parkin-mitophagy: HIF-3α (a HIF-family paralog central to metabolic aging) is placed upstream of BNIP3-driven receptor-mediated mitophagy in aged cardiomyocytes, tying the hypoxia-signaling axis directly to selective mitochondrial clearance. (novelty: 3)
- 2026-08-28 — Oxygenaging: A Physiological Framework for Geroscience: cross-connection with oxygenaging: Oxygenaging framework foregrounds HIF-mediated oxygen sensing as a mechanistic pillar linking tissue hypoxia responses to age-related metabolic dysregulation. (novelty: 3)
- 2026-07-01 — Syringaresinol Attenuates Aging-Associated Ferroptosis-Relevant Stress Through an HIF-1α-GPX4 Defense Axis.: cross-connection with ferroptosis: Syringaresinol finding proposes HIF-1α as an upstream inducer of GPX4-mediated ferroptosis defense in aged human fibroblasts, coupling HIF-1α biology beyond its metabolic-aging role to lipid-peroxidation control. (novelty: 3)
- 2026-08-26 — Rapamycin attenuates age-related atrial remodeling and fibrillation by targeting HIF-1α-mediated metabolic dysregulation.: D-galactose aging mouse model: HIF-1α expression and nuclear translocation rise in aged atria and drive metabolic dysregulation underlying atrial fibrillation; rapamycin suppresses HIF-1α signaling and rescues atrial remodeling, with evidence suggesting partly mTOR-independent (possibly direct dimerization-interfering) action. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Rapamycin attenuates age-related atrial remodeling and fibrillation by targeting HIF-1α-mediated metabolic dysregulation.
26-aug-2026
novelty 3
per-area 3
strengthens